Evidence report · Hormones and women's health

Is HRT safe? Hormone therapy at menopause

Verdict on whether hormone therapy around menopause does more good than harm for most women: Leaning for. Hormone therapy (HRT/MHT) is a reasonable and often helpful option for many women near menopause onset, and the blanket fear after the WHI study was an overcorrection. Transdermal estradiol with micronized progesterone is the preferred form. It is a decision to make with a menopause-trained clinician, not a self-prescribed protocol.

Best for:
women near menopause onset, deciding with a menopause-trained clinician.
Price:
Free to read, with every receipt. Pro is $9 a month or $79 a year and adds AI Ask.

45 sources credited48 counted mentions18 episodes · 34 h48 checked quotesChecked against the tape 2026-06-24

Stance update (Aug 2026): An episode on hormones in psychiatry (#404) extends the WHI argument past breast cancer and into mood. A psychiatrist of 35 years said the reinterpretation of the Women's Health Initiative "changed prescribing practices so profoundly in general medicine" that he retrained in hormone therapy. He described women "whose adaptive capacities were higher, their ability to self-regulate and adjust to internal and external threats and changes was being eroded off of estradiol." The mechanism given is that estradiol modulates serotonin, dopamine, GABA, acetylcholine and glutamate signaling rather than boosting one of them, a different claim from the heart and cancer questions the WHI debate usually turns on. Source: youtube.com/watch?v=fs89fhQCfj4 at 54:14.

Stance update (Nov 2025): The U.S. FDA moved to remove the boxed ("black box") warning on menopausal hormone therapy: the warnings for cardiovascular disease, breast cancer and probable dementia. It is the regulatory catch-up to the WHI reframe. The endometrial-cancer warning for systemic estrogen-only therapy (in women with a uterus) stays. Label rewrites roll out over roughly six months, with new guidance noting benefits when therapy starts within ~10 years of menopause onset.

Benefits: does it work?

Each claim gets one verdict, worked out from every counted mention. One dot is one source: a researcher or a study. Tap a dot to see its receipt.

positive partly neutral negative Each researcher and each study counts once per claim, however often they come up.

  1. Leaning for

    Hormone therapy around menopause does more good than harm for most women.

    12 sources: 4 positive, 8 partly.

    Researchers say

    3 positive, 5 partly

    Studies show

    1 positive, 3 partly

    4 cited on tape, not yet checked against the paper

    110 more not counted · see why
    We could not tell what position it takes on this claim. 37
    We could not confirm who is speaking. 30
    The study cited could not be identified. 12
    We could not tell where the evidence comes from. 11
    A host's remark inside an interview. 11
    The same study is already counted once. 4
    No reader has judged its stance yet. 4
    No quote from the tape on record yet. 1
    Show the receipts from 12 sources
    1. Sarah Zal, on The Diary Of A CEO, at 1:15:39 Video · positive · Opinion

      “And by that I mean using hormone therapy and using lifestyle medicine as early as possible to manage that transition.”

    2. Brian Kennedy, on The Drive, at 1:29:47 Video · positive · Opinion

      “I just see the the value of of hormone replacement to far outweigh the risk in the majority of women.”

    3. Rachel Rubin, on The Drive, at 01:47 Video · positive · Opinion

      “So anyone should be offered hormone therapy because who wouldn't want to prevent osteoporosis”

    4. Danish Osteoporosis Prevention Study, cited on The Dr. Hyman Show, at 1:11:29 Study · positive

      “the women who were on hormone therapy had a decreased risk of cardiovascular disease”

    5. Dr. Mary Claire Haver, on Huberman Lab, at 2:03:48 Video · partly · Opinion

      “it will always protect her bones it will always protect her genital urinary system it will always protect her skin”

    6. Joanne Manson Video · partly · 2 mentions

      on The Drive, at 49:51 · partly · Opinion

      “for a woman in early menopause at usual risk of breast cancer who would derive the benefits of symptom relief”

      on The Drive, at 1:15:06 · partly · Opinion

      “in early menopause and generally good health the benefits are likely to outweigh the risk”

    7. Dr. Annice Mukherjee, on Rangan Chatterjee's channel, at 46:34 Video · partly · Opinion

      “the during the time she's got symptoms, which are for most women time limited, hormone therapy um has much more greater benefits than than harms.”

    8. Dr. Lauren Colenso-Semple, on Huberman Lab, at 2:08:45 Video · partly · Opinion

      “this is is really powerful and can be really effective for symptoms.”

    9. Dr. Stacy Sims, on Rangan Chatterjee's channel, at 1:48:42 Video · partly · Opinion

      “using menopause hormone therapy in conjunction to lifestyle is a win, but it's not for everyone.”

    10. American Heart Association 2020, cited on Huberman Lab, at 1:13:47 Study · partly

      “if you started hormone therapy between the ages of 50 to 59 you had a 50% decreased risk of cardiovascular disease”

    11. Women's Health Initiative, cited on The Dr. Hyman Show, at 54:55 Study · partly

      “the earlier you start in this process, the more long-term benefit you're going to get.”

    12. Levy and Simon, Obstetrics and Gynecology 2024, cited on The Dr. Hyman Show, at 28:53 Study · partly

      “we have a window of opportunity for protection for cardiovascular disease”

2 more claims on dose, form and timing, each with its verdict and receipts, are in the full report.

How much, which type, and when?

Free with an account ↓
Dosage
Form
Timing
Evidence
Verdict
Leaning for · 12 sources: 4 positive, 8 partly

Is it safe for me?

5 risks to check before you start

  1. Nothing here is medical advice. Any decision to start, stop or change hormone therapy belongs with a menopause-trained doctor who knows your history.
  2. The breast-cancer picture is reassuring overall but not zero. Estrogen alone showed no rise in risk and the combined absolute risk is small (Sharon Malone, on The Doctor's Farmacy). Women with a personal or strong family history of hormone-sensitive cancer need a specialist's individual decision, not a blanket yes or no.
  3. Route changes the risk. Oral estrogen raises clotting risk through the liver, with VTE, stroke and gallbladder disease cited as downsides. Transdermal estradiol largely avoids it (Mary Claire Haver, on Huberman Lab; Avrum Bluming, on The Drive).
  4. Contraindications named include active hormone-sensitive cancer, undiagnosed vaginal bleeding and severe or active liver disease. These need a clinician, and a past cancer does not settle the question either way (Mary Claire Haver, on Huberman Lab).
  5. Avoid fringe practices: compounded 'bioidentical' pellets, saliva hormone tests and unproven anti-aging hormone schemes. Get care from a qualified menopause specialist, not a wellness sales funnel (Rachel Rubin, on The Drive).

Why do the sources disagree?

Built from every credited researcher and cited study on each claim.

Leaning for

Hormone therapy around menopause does more good than harm for most women.

Supports it 4 sources

Researchers

Studies

Partly 8 sources

Researchers

Studies

Precis is not affiliated with or endorsed by YouTube or by any researcher, show or publisher we quote. We take no sponsorship, ad or affiliate money, and every verdict is our own review of what was said. How we stay independent

About This Analysis

This report on HRT & Menopause draws on 18 videos (34 hours analyzed) out of 3,800+ hours of recorded interviews with 380+ researchers and doctors, plus 87,700+ research studies. Every mention of a claim gets a stance, and the verdict is worked out from all of them, never written by hand.

The full report adds 8 key findings and the dose and protocol. It also has the verdict on every claim, a receipt for each mention, the risks to check, and what combines with it.

Frequently Asked Questions

What does the evidence say about hrt & menopause?
Hormone therapy (HRT/MHT) is a reasonable and often helpful option for many women near menopause onset, and the blanket fear after the WHI study was an overcorrection. Transdermal estradiol with micronized progesterone is the preferred form.
How strong is the evidence on hrt & menopause?
The verdict on “Hormone therapy around menopause does more good than harm for most women” is Leaning for. 12 sources: 4 positive, 8 partly.

Common Questions

Related Reports

Unlock the Full Report

Get dosages, timing and the verdict on every claim with its receipts for HRT & Menopause.